ConductScience.org, home
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
API referenceFor AI assistants

Trial · NCT00819234

Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDPlacebo - Stable31
Overall StudySTARTED360 mcg Pramlintide + 1.25mg Metreleptin - Stable35
Overall StudySTARTED360 mcg Pramlintide + 2.5 Metreleptin - Stable36
Overall StudySTARTED360 mcg Pramlintide + 5.0 Metreleptin - Stable28
Overall StudySTARTED360 mcg Pramlintide + 1.25 mg Metreleptin - Prior Monotherapy13
Overall StudySTARTED360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Monotherapy14
Overall StudySTARTED360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Monotherapy13
Overall StudySTARTED360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Metre Mono29
Overall StudySTARTED360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Lower Pram37
Overall StudySTARTED360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Lower Pram37
Overall StudyCOMPLETEDPlacebo - Stable21
Overall StudyCOMPLETED360 mcg Pramlintide + 1.25mg Metreleptin - Stable20
Overall StudyCOMPLETED360 mcg Pramlintide + 2.5 Metreleptin - Stable28
Overall StudyCOMPLETED360 mcg Pramlintide + 5.0 Metreleptin - Stable22
Overall StudyCOMPLETED360 mcg Pramlintide + 1.25 mg Metreleptin - Prior Monotherapy12
Overall StudyCOMPLETED360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Monotherapy7
Overall StudyCOMPLETED360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Monotherapy8
Overall StudyCOMPLETED360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Metre Mono20
Overall StudyCOMPLETED360 mcg Pramlintide + 2.5 mg Metreleptin - Prior Lower Pram31
Overall StudyCOMPLETED360 mcg Pramlintide + 5.0 mg Metreleptin - Prior Lower Pram30

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00819234/flow

API referenceFor AI assistants